GlassScriptPhysician profile
Arif Sheikh
NPI 1881653038
$5,344.41
in general payments reported to CMS, 2019-2025
7 companies · $4,690 in 2025
The $4,690 reported for 2025 was more than what 92% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.09 · 2022: $131 · 2023: $502 · 2025: $4,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,175 · Travel and Lodging: $1,923 · Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,175.00 |
| Travel and Lodging | $1,922.63 |
| Food and Beverage | $1,094.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $2,652.03 | 2022-2025 | Illuccix |
| Novartis Pharmaceuticals Corporation | $2,175.00 | 2025 | |
| Ge Healthcare | $232.44 | 2023-2025 | |
| Voximetry, INC. | $147.40 | 2023 | Torch |
| Pfizer INC. | $101.31 | 2022 | |
| Blue Earth Diagnostics | $21.09 | 2021 | |
| Siemens Medical Solutions USA, INC. | $15.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arif Sheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.